richeldi

Accused of sexual assault on a patient, pulmonologist Luca Richeldi asks for a plea deal

L'Unione Sarda.it - 07 May 2024
Accused of sexual assault on a patient, pulmonologist Luca Richeldi asks for a plea deal ...

Professor Luca Richeldi Indicted for Sexual Assault: Trial Set for June 3 - Il Messaggero

English edition - 02 Oct 2024
Professor Luca Richeldi Indicted for Sexual Assault: Trial Set for June 3 ...

Lung Disease: In Clinical Trial New Boehringer Ingelheim Drug Prevented Worsening of IPF

MedicalResearch.com - 15 May 2024
Lung Disease: In Clinical Trial New Boehringer Ingelheim Drug Prevented Worsening of IPF ...

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

nejm.org - 15 May 2022
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis ...

Advancing Care for Idiopathic Pulmonary Fibrosis (IPF): Evaluating Current Treatments and Emerging Therapies for Improved Patient Outcomes

AJMC.com Managed Markets Network - 30 Sep 2024
Advancing Care for Idiopathic Pulmonary Fibrosis (IPF): Evaluating Current Treatments and Emerging Therapies for Improved Patient Outcomes ...

(PDF) Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis

ResearchGate - 22 Oct 2024
(PDF) Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis ...

Luca Richeldi: high hopes for rare lung diseases

The Lancet - 13 May 2017
Luca Richeldi: high hopes for rare lung diseases ...

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

nejm.org - 18 May 2014
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis ...

Idiopathic pulmonary fibrosis: moving forward

BMC Medicine - 24 Sep 2015
Idiopathic pulmonary fibrosis: moving forward ...

Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics

ScienceDirect.com - 23 May 2022
Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics ...

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis

Frontiers - 09 Feb 2024
Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis ...

Idiopathic pulmonary fibrosis

The Lancet - 05 May 2018
Idiopathic pulmonary fibrosis ...

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

nejm.org - 22 Sep 2011
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis ...

Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society | Radiology

RSNA Publications Online - 12 Jan 2021
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society | Radiology ...